Selective cyclo‐oxygenase 2 inhibition affects ileal but not colonic anastomotic healing in the early postoperative period
暂无分享,去创建一个
[1] Y. Sonmez. The Effect of Prostaglandin E1 on Colonic Anastomotic Healing A Comparison Study , 2005 .
[2] H. Redmond,et al. Effects of a selective cyclo‐oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity , 2004, The British journal of surgery.
[3] Y. Surh,et al. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. , 2004, Biochemical pharmacology.
[4] Y. An,et al. Is there an inhibitory effect of COX-2 inhibitors on bone healing? , 2004, Pharmacological research.
[5] J. DeGroot,et al. Increased expression of matrix metalloproteinases in the murine zymosan‐induced multiple organ dysfunction syndrome , 2004, The Journal of pathology.
[6] J. Rømsing,et al. A systematic review of COX‐2 inhibitors compared with traditional NSAIDs, or different COX‐2 inhibitors for post‐operative pain , 2004, Acta anaesthesiologica Scandinavica.
[7] J. Mitchell,et al. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] C. Maglione,et al. Gastrointestinal Damage Induced by Celecoxib and Rofecoxib in Rats , 2001, Digestive Diseases and Sciences.
[9] E. Hawk,et al. Cyclooxygenase inhibition in cancer prevention and treatment , 2003, Expert opinion on pharmacotherapy.
[10] J. Wallace,et al. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction , 2003, Gut.
[11] J. Galanko,et al. PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[12] H. van Goor,et al. Colonic anastomotic strength and matrix metalloproteinase activity in an experimental model of bacterial peritonitis , 2003, The British journal of surgery.
[13] I. de Hingh,et al. Doxycycline improves wound strength after intestinal anastomosis in the rat. , 2003, Surgery.
[14] J. Casler,et al. Selective cyclooxygenase‐2 inhibition does not affect the healing of cutaneous full‐thickness incisional wounds in SKH‐1 mice , 2003, The British journal of dermatology.
[15] Per Aspenberg,et al. Indomethacin and celecoxib improve tendon healing in rats , 2003, Acta orthopaedica Scandinavica.
[16] J. Frölich,et al. The second generation of COX-2 inhibitors: what advantages do the newest offer? , 2003, Drugs.
[17] F. Marks,et al. The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin. , 2002, The Journal of investigative dermatology.
[18] Y. Fukuda,et al. Wound Healing Involves Induction of Cyclooxygenase-2 Expression in Rat Skin , 2002, Laboratory Investigation.
[19] J. Rho,et al. Both Constitutive and Inducible Prostaglandin H Synthase Affect Dermal Wound Healing in Mice , 2002, Laboratory Investigation.
[20] I. de Hingh,et al. The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat , 2002, International Journal of Colorectal Disease.
[21] M. Hsiao,et al. Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats. , 2002, European journal of oral sciences.
[22] T. Sorsa,et al. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. , 2002, Journal of periodontology.
[23] P. Weinhold,et al. A Cyclooxygenase-2 Inhibitor Impairs Ligament Healing in the Rat , 2001, The American journal of sports medicine.
[24] A. Tarnawski,et al. Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives , 2001, Gut.
[25] B. Jeppsson,et al. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model , 2001, The British journal of surgery.
[26] J. Meyer-Kirchrath,et al. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. , 2000, Current medicinal chemistry.
[27] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[28] J Y Zhang,et al. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[29] J. Wallace,et al. Wound collagen deposition in rats: effects of an NO‐NSAID and a selective COX‐2 inhibitor , 2000, British journal of pharmacology.
[30] T. Wobbes,et al. Post-operative levamisole may compromise early healing of experimental intestinal anastomoses. , 1995, British Journal of Cancer.
[31] P. Oliveira,et al. Influence of misoprostol, a synthetic prostaglandin E1 analog, on the healing of colonic anastomoses in rats , 1994, Diseases of the colon and rectum.
[32] A. Macpherson,et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.
[33] João Batista de Sousa,et al. Effects of diclofenac sodium on intestinal anastomotic healing , 1991, Diseases of the colon and rectum.
[34] T. Hendriks,et al. The influence of NSAIDs on experimental intestinal anastomoses , 1991, Diseases of the colon and rectum.
[35] Y. Sonmez,et al. The effect of prostaglandin E1 on colonic anastomotic healing , 1990, Diseases of the colon and rectum.
[36] D. Leaper,et al. Prostaglandins in colonic anastomotic healing , 1984, Diseases of the colon and rectum.